Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Pharmacol Sci ; 143(1): 30-38, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32151540

RESUMO

The role of nitric oxide (NO) on intestinal mucosal injury induced by single or consecutive administration of methotrexate was investigated in a rodent model. Rats received methotrexate intraperitoneally either as a single administration (50 mg/kg) or as a consecutive administration (12.5 mg/kg/day) for 4 days. NG-nitro-l-arginine methyl ester (L-NAME) was given subcutaneously to inhibit NO synthase (NOS). Ninety-six hours after the first administration of methotrexate, ileal tissues were collected for analysis. Consecutive administration of methotrexate led to decreased body weight and reduced intake of food and water, which were further worsened by L-NAME. Although a slight mucosal injury resulted from single administration of methotrexate, L-NAME had almost no effect. Consecutive administration of methotrexate caused a significant mucosal injury, which was further worsened by L-NAME. Consecutive, but not single, administration of methotrexate induced mRNA expression of inflammatory cytokines in ileal tissue. Consecutive administration of methotrexate significantly induced constitutive NOS expression in ileal tissue. These results suggest that consecutive administration, rather than single administration, of methotrexate aggravates mucosal injury. Potentiation of constitutive NOS expression by consecutive administration might be one of the main reason to antagonize the intestinal mucosal injury as well as lead to a reduction in rat quality of life.


Assuntos
Expressão Gênica , Enteropatias/etiologia , Intestino Delgado/metabolismo , Intestino Delgado/patologia , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Óxido Nítrico/efeitos adversos , Óxido Nítrico/metabolismo , Animais , Citocinas/genética , Citocinas/metabolismo , Mediadores da Inflamação/metabolismo , Masculino , Modelos Animais , Óxido Nítrico/genética , RNA Mensageiro/metabolismo , Ratos Wistar
2.
Pharmacology ; 105(11-12): 723-728, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32694256

RESUMO

This study aimed to investigate whether the consecutive administration of methotrexate affects 5-hydroxytryptamine (5-HT) synthesis in the rat small intestine. Rats received methotrexate at a dose of 12.5 mg/kg intraperitoneally on 4 consecutive days. NG-nitro-L-arginine methyl ester (L-NAME) was given subcutaneously to inhibit nitric oxide (NO) synthase. Methotrexate moderately altered 5-HT synthesis, whereas the combined administration of methotrexate and L-NAME significantly changed 5-HT synthesis in the rat ileal tissue. These results suggest that endogenous NO has an antagonistic role in the induction of 5-HT synthesis in rats following the consecutive administration of methotrexate.


Assuntos
Inibidores Enzimáticos/farmacologia , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Metotrexato/farmacologia , Óxido Nítrico/metabolismo , Serotonina/biossíntese , Animais , Esquema de Medicação , Inibidores Enzimáticos/administração & dosagem , Injeções Intraperitoneais , Enteropatias/induzido quimicamente , Intestino Delgado/patologia , Masculino , Metotrexato/administração & dosagem , NG-Nitroarginina Metil Éster/administração & dosagem , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Substância P/efeitos dos fármacos , Substância P/metabolismo , Taquicininas/efeitos dos fármacos , Taquicininas/genética , Taquicininas/metabolismo , Triptofano Hidroxilase/efeitos dos fármacos , Triptofano Hidroxilase/genética , Triptofano Hidroxilase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA